Clinical trial of a new synthetic anticoagulant: LD 4610
Acar, J.
Annales de Cardiologie et d'Angeiologie 21(4): 393-395
1972
ISSN/ISBN: 0003-3928 PMID: 4652250 Document Number: 51014
Document emailed within 1 workday
Related Documents
Napoli, A.; Alderuccio, B.; Nannetti, A. 1977: Treatment of degenerative and inflammatory joint diseases with or without a new synthetic substance (parsalmide). Controlled clinical trial La Clinica Terapeutica 83(5): 541-547Stevens, R.E.; Hanford, K.; Wason, S.; Cusack, S.L.; Phelps, K.V. 2000: A 12-week clinical trial determining the efficacy of synthetic conjugated estrogens, a (SCE), in the treatment of vasomotor symptoms in menopausal women International Journal of Fertility and Women's Medicine 45(4): 264-272
Faldini, A.; Marchetti, N. 1970: Clinical trial of a new synthetic product: o-ethoxybenzylhydrazone of diethanolamine pyruvate associated with vitamins B 1, B 6 and B 12 and dichloroethanoate of diisopropylammonium in the treatment of rheumatic and neuritic pain syndromes Minerva Ortopedica 21(1): 51-56
Spinner, D.; Walter, J.; Vazquez-Gragg, M.; Bloise, T.; Stafford-Smith, M.; Faulkner, E.; Taekman, J. 2011: Php74 Clinical Trial Learning Curves Affect Outcomes Measurement, Patient Safety and Trial Success: Contributing Factors and a Potential Solution in Clinical Trial Simulation Value in Health 14(3): A24-A25
Mbuagbaw, L.; Thabane, L.; Ongolo-Zogo, P.; Lang, T. 2011: The challenges and opportunities of conducting a clinical trial in a low resource setting: the case of the Cameroon mobile phone SMS (CAMPS) trial, an investigator initiated trial Trials 12: 145
Galler, A.S.; Bauer, T.L. 2009: A randomised phase II trial of preoperative chemotherapy of cisplatindocetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG 0204) Yearbook of Oncology 2009: 194-195
Hu, D.; Xu, Z. 1997: Multicenter clinical trial of thrombolytic therapy in 1,406 patients with acute myocardial infarction. Collaborative Group of Clinical Trial for Urokinase Therapy Chinese Medical Journal 110(11): 839-842
Lechat, P.; Lardoux, H.; Mallet, A.; Sanchez, P.; Derumeaux, G.; Lecompte, T.; Maillard, L.; Mas, J.L.; Mentré, F.; Pousset, F.; Lacomblez, L.; Pisica, G.; Solbes-Latourette, S.; Raynaud, P.; Chaumet-Riffaud, P. 2000: Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. a randomized trial (FFAACS) Therapie 55(6): 681-689
Podoprigorova, V.G.; Khibin, L.S.; Kozlov, N.B.; Barsel', V.A. 1999: Effectiveness of synthetic antioxidants in treatment of patients with peptic ulcer (an open randomized controlled trial) Klinicheskaia Meditsina 77(3): 32-35
Beurton, D.; Pascal, B.; Bronstein, M.; Lepage, T.; Ridoux, G.; Cukier, J. 1979: Medical treatment of ureteral calculi. Therapeutic trial with a synthetic anti-inflammatory agent in 97 patients (proceedings) Journal d'Urologie et de Nephrologie 85(3): 260-264
O'Keefe, S.J.; Spitaels, J.M.; Mannion, G.; Naiker, N. 1985: Misoprostol, a synthetic prostaglandin E1 analogue, in the treatment of duodenal ulcers. A double-blind, cimetidine-controlled trial South African Medical Journal 67(9): 321-324
Byshevskiĭ, A.S.; Sokolovskiĭ, S.R. 1982: Potentiation of the anticoagulant effects of a phosphatidylserine-containing anticoagulant and heparin Voprosy Meditsinskoi Khimii 28(2): 30-34
Ting, C.Y.; Ting, R.S.-K.; Lim, C.J.; King, T.L.; Ting, H.; Gerofi, J. 2019: Pilot study on functional performance and acceptability of two new synthetic adhesive male condoms (Wondaleaf): a randomized cross-over trial Contraception 100(1): 65-71
Ndebele, P.M.; Wassenaar, D.; Munalula, E.; Masiye, F. 2012: Improving understanding of clinical trial procedures among low literacy populations: an intervention within a microbicide trial in Malawi Bmc Medical Ethics 13: 29
Evans, S.; Pocock, S. 2001: Societal responsibilities of clinical trial sponsors. Lack of commercial pay off is not a legitimate reason for stopping a trial Bmj 322(7286): 569-570
Stevenson, D.; Walther, F.; Long, W.; Sell, M.; Pauly, T.; Gong, A.; Easa, D.; Pramanik, A.; LeBlanc, M.; Anday, E. 1992: Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I Journal of Pediatrics 120(2 Pt 2): S3-12
Egorova, V.V.; Berkovskiĭ, A.L.; Sergeeva, E.V.; Vasil'ev, S.A.; Karelin, A.A.; Titova, M.I.; Nazarenko, N.A.; Zemlianoĭ, A.B. 2002: Disorders of protein C anticoagulant system in various clinical conditions Klinicheskaia Meditsina 80(11): 46-50
Petterino, C.; Paolo, B.; Tristo, G. 2004: Clinical and pathological features of anticoagulant rodenticide intoxications in dogs Veterinary and Human Toxicology 46(2): 70-75
Goldberg, Y.; Berliner, S.; Seligsohn, U. 2002: Clinical and economical advantages of anticoagulant treatment in specialized clinics Harefuah 141(9): 830
Toulon, P. 2001: Clinical usefulness of global assays of the anticoagulant pathway of protein C Annales de Biologie Clinique 59(5): 545-550